Serum enterolactone levels and mortality outcome in women with early breast cancer: A retrospective cohort study

Breast Cancer Research and Treatment

Volumn 132, Issue 2, 2012, Pages 661-668

  Guglielmini, Pamela ^a   Rubagotti, Alessandra ^a,b   Boccardo, Francesco ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Early breast cancer; Mortality; Serum enterolactone

Indexed keywords

ANTINEOPLASTIC AGENT; ENTEROLACTONE; LIGNAN; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; CRYOPRESERVATION; EARLY CANCER; FEMALE; FLUOROIMMUNOASSAY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY;

4-BUTYROLACTONE; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; FLUOROIMMUNOASSAY; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; LIGNANS; MASTECTOMY; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84859106243     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1881-8     Document Type: Article

References (23)

1. Reinli K, Block G (1996) Phytoestrogen content of foods-a compendium of literature values. Nutr Cancer 26:123-148 (Pubitemid 26300193)
2. Mazur W (1998) Phytoestrogen content in foods. Bailliere's Clin Endocrinol Metab 12:729-742
3. Adlercreutz H (2002) Phyto-oestrogens and cancer. Lancet Oncol 3:364-373
4. Boccardo F, Puntoni M, Guglielmini P et al (2006) Enterolactone as arisk factor for breast cancer: a review of the published evidence. Clin Chim Acta 365:58-67 (Pubitemid 43196417)
5. Buck K, Zaineddin AK, Vrieling A et al (2010) Meta-analyses of lignans and enterolignans in relation to breast cancer risk. Am J Clin Nutr 92:141-153
6. Boccardo F, Lunardi G, Guglielmini P et al (2004) Serum enterolactone levels and the risk of breast cancer in women with palpable cysts. Eur J Cancer 40:84-89 (Pubitemid 37542321)
7. Boccardo F, Lunardi GL, Petti AR et al (2003) Enterolactone in breast cyst fluid: correlation with EGF and breast cancer risk. Breast Cancer Res Treat 79:17-23 (Pubitemid 36561039)
8. Brooks JD, Thompson LU (2005) Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells. J Steroid Biochem Mol Biol 94:461-467 (Pubitemid 40616407)
9. Bergman JM, Thompson LU, Dabrosin C (2007) Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin Cancer Res 13:1061-1067 (Pubitemid 46340386)
10. Kitts DD, Yuan YV, Wijewickreme AN et al (1999) Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol Cell Biochem 202:91-100 (Pubitemid 30099742)
11. Chen J, Stavro PM, Thompson LU (2002) Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulates expression of insulin-like growth factor and epidermal growth factor receptor. Nutr Cancer 43:187-192 (Pubitemid 36134093)
12. McCann SE, Thompson LU, Nie J et al (2009) Dietary lignan intakes in relation to survival among women with breast cancer: The Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat 122:229-235
13. Fink BN, Steck SE, Wolff MS et al (2007) Dietary flavonoid intake and breast cancer survival among women on Long Island. Cancer Epidemiol Biomarkers Prev 16:2285-2292 (Pubitemid 351196361)
14. Olsen A, Christensen J, Knudsen KE et al (2011) Prediagnostic plasma enterolactone levels and mortality among women with breast cancer. Breast Cancer Res Treat 128:883-889
15. Buck K, Vrieling A, Zaineddin AK et al (2011) Serum enterolactone and prognosis of postmenopausal breast cancer. J Clin Oncol 29:3730-3738
16. Stumpf K, Uehara M, Nurmi T et al (2000) Changes in the timeresolved fluoroimmunoassay of plasma enterolactone. Am Biochem 15:153-157
17. Kaplan EL, Meier P (1958) Non parametric estimation from incomplete observation. J Am Stat Assoc 53:457-481
18. Cox DR (1972) Regression models and life tables (with discussion). J Royal Statist Soc B 34:187-220
19. Gray RJ (1988) A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16: 1141-1154
20. Zeleniuch-Jacquotte A, Adlercreutz H, Akhmedkhanov A et al (1998) Reliability of serum measurements of lignans and isoflavonoid phytoestrogens over a two-year period. Cancer Epidemiol Biomarkers Prev 7:885-889 (Pubitemid 28471576)
21. Wang L, Chen J, Thompson LU (2005) The inhibitory effect of flaxseed on the growth and metastasis of estrogen receptor negative human breast cancer xenografts is attributed to both its lignan and oil components. Int J Cancer 116:793-798 (Pubitemid 41099712)
22. Chen J, Wang L, Thompson LU (2006) Flaxseed and its components reduce metastasis after surgical excision of solid human breast tumor in nude mice. Cancer Lett 234:168-175
23. Chen J, Chen J, Thompson LU (2003) Lignans and tamoxifen, alone or in combination, reduce human breast cancer cell adhesion, invasion and migration in vitro. Breast Cancer Res Treat 80:163-170 (Pubitemid 36886504)